Clinical Trial Update: Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers an intravitreal adalimumab study for inherited and degenerative retinal diseases, including Retinitis Pigmentosa and Extensive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive Macular Atrophy with Pseudodrusen
• Retinitis Pigmentosa

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Centro de Pesquisa Rubens Siqueira | Conditions: Retinitis Pigmentosa (RP), Extensive Macular Atrophy With Pseudodrusen (EMAP) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING